GLP-1 medications like semaglutide and tirzepatide have demonstrated impressive efficacy in clinical trials, facilitating weight loss of approximately 10% to over 17% of total body weight
Time-strapped prescribing physicians are also turning to dietitians to lead nuanced conversations around weight loss and eating behavior
Proper storage is also important
Common experiences at 1 mg include mild nausea in the first 24 to 48 hours after injection, particularly after the first dose
Approximately 10% of patients with a nevus of Ota develop glaucoma, and ipsilateral sensorineural hearing loss has also been described
Lastly, slides were counterstained with Mayers Hematoxylin (Electron Microscopy Sciences, 26609-03), dehydrated through an ascending alcohol gradient and placed in xylene, and cover slipped